Mode
Text Size
Log in / Sign up

High-risk adiposity and inflammation trajectories correlate with significantly increased risk of incident Type 2 DiabetesAdiposity and Inflammation Levels Linked to Type 2 Diabetes Risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that high-risk trajectories of adiposity and inflammation are associated with significantly increased risk of Type 2 Diabetes.

This meta-analysis synthesizes data from a bi-cohort prospective study involving 3,733 diabetes-free adults aged 50 years and older. The study analyzed the joint trajectories of adiposity and systemic inflammation, specifically looking at general adiposity (BMI and C-reactive protein) and central adiposity (waist-to-height ratio and C-reactive protein) over an approximately 8-year follow-up period.

Key findings indicate that the highest-risk group in the general adiposity strategy had an elevated risk of incident diabetes (HR 6.00; 95% CI 3.71-9.70). Similarly, the highest-risk group in the central adiposity strategy showed a substantially elevated risk (HR 5.69; 95% CI 3.37-9.59). Regarding the mediation of risk by HbA1c, the effect was mediated by 13.7-27.5% under a conservative definition and 25.7-44.8% under the original definition.

While trajectory modeling showed modestly higher C-statistics over baseline cross-classification (deltaC 0.061-0.067), the authors note that these discriminative gains were modest. The findings suggest that monitoring both adiposity and inflammation may provide useful clinical information for risk stratification in older adults, though the results represent an association rather than a causal link.

How this fits prior evidence

This finding addresses a gap in identifying early risk markers for Type 2 Diabetes in aging populations by focusing on the interplay between adiposity and inflammation. While other evidence highlights the role of allostatic load as a predictor of outcomes and the impact of pharmacist-led interventions on glycemic control, this study specifically quantifies the risk associated with joint trajectories of adiposity and inflammation.

Researchers analyzed data from over 3,700 adults aged 50 and older who did not have diabetes at the start of the study. They looked at how changes in body fat and systemic inflammation over an eight-year period related to the development of Type 2 Diabetes. The study tracked two different paths: general body fat and central fat (fat around the waist).

Findings showed that people in the highest risk groups for both types of fat and inflammation had a significantly higher risk of developing diabetes. Specifically, the risk was over five times higher for those with high levels of both factors. The study also looked at how blood sugar levels, measured as HbA1c, played a role in this risk.

While the results show a clear link between these factors and diabetes, it is important to remember that this was an observational study. This means the researchers found a connection, but they cannot say that the fat and inflammation caused the diabetes. These findings suggest that monitoring both body fat and inflammation together could help doctors better identify who might need extra care as they age.

What this means for you:
Tracking changes in body fat and inflammation over time is linked to a higher risk of Type 2 Diabetes.

Common questions

Who was included in this study?

The study included 3,733 adults who were at least 50 years old and did not have diabetes at the beginning of the research. The study followed these individuals for approximately 8 years to see how their health changed over time.

What specific factors were linked to diabetes risk?

The study looked at the link between body fat (both general and central) and systemic inflammation. People in the highest risk groups for these factors showed a significantly higher risk of developing Type 2 Diabetes compared to others.

How much of the risk was related to blood sugar levels?

The study looked at how much of the risk was explained by HbA1c, which measures average blood sugar. Depending on the definition used, HbA1c was found to account for between 13.7% and 44.8% of the total effect on diabetes risk.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BackgroundObesity and chronic low-grade inflammation are established risk factors for type 2 diabetes, yet their joint longitudinal evolution and combined contribution to diabetes incidence remain poorly characterized in aging populations.ObjectiveTo identify joint trajectories of adiposity and systemic inflammation, evaluate their associations with incident diabetes, and quantify the mediating role of glycated hemoglobin (HbA1c) across two independent cohorts.MethodsThis prospective study included 3,733 diabetes-free adults aged ≥50 years from the English Longitudinal Study of Ageing (ELSA, n = 1,778) and the Health and Retirement Study (HRS, n = 1,955), with approximately 8 years of follow-up. Group-based multi-trajectory modeling identified joint trajectory groups under two strategies: general adiposity (body mass index paired with log-transformed C-reactive protein) and central adiposity (waist-to-height ratio paired with log-transformed C-reactive protein). Associations with incident diabetes were estimated using Cox proportional hazards models pooled via random-effects meta-analysis. Mediation analysis quantified the proportion statistically mediated through mid-wave HbA1c.ResultsFour trajectory groups were identified under each strategy in both cohorts. A graded association was observed: the highest-risk group exhibited substantially elevated diabetes risk under both general adiposity (pooled HR 6.00, 95% CI 3.71–9.70) and central adiposity strategies (pooled HR 5.69, 95% CI 3.37–9.59) after full adjustment. Under the conservative outcome definition, HbA1c mediated 13.7–27.5% of the total effect (25.7–44.8% under the original definition representing an upper bound). Trajectory classification yielded modestly higher C-statistics over baseline cross-classification (ΔC 0.061–0.067, statistically significant in HRS), with significant net reclassification improvement primarily driven by event cases. Results were consistent across strategies and cohorts.ConclusionCo-evolving trajectories of adiposity and systemic inflammation exhibit a graded association with incident diabetes in older adults, partially mediated through glycemic deterioration. Trajectory modeling offered modest discriminative gains over single-time-point assessment. These findings support concurrent adiposity-inflammation monitoring for diabetes risk stratification in aging populations.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.